ARIAD Pharmaceuticals, Inc.
(NASDAQ : ARIA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.48%171.281.3%$490.30m
BIIBBiogen Inc.
-0.90%227.061.3%$435.96m
CELGCelgene Corporation
-0.41%95.241.3%$435.38m
GILDGilead Sciences, Inc.
-0.42%66.890.9%$421.14m
ILMNIllumina, Inc.
1.13%312.453.5%$304.49m
REGNRegeneron Pharmaceuticals, Inc.
-0.86%312.562.6%$284.79m
AAgilent Technologies, Inc.
0.99%68.371.6%$218.10m
VRTXVertex Pharmaceuticals Incorporated
-0.72%171.771.9%$178.12m
EXASExact Sciences Corporation
3.06%96.8825.3%$165.46m
ALXNAlexion Pharmaceuticals, Inc.
1.45%127.152.0%$148.25m
BMRNBioMarin Pharmaceutical Inc.
2.42%89.074.3%$119.32m
INCYIncyte Corporation
1.55%81.752.5%$110.60m
SRPTSarepta Therapeutics, Inc.
2.19%120.8414.7%$106.75m
ALNYAlnylam Pharmaceuticals, Inc
1.50%68.939.2%$99.72m
IONSIonis Pharmaceuticals, Inc.
-3.60%64.728.2%$96.34m

Company Profile

ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA.